Four new products have been recommended for approval in Japan

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1404, 2003-01, pp. : 22-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tiotropium bromide [Spiriva; Boehringer Ingelheim] and peginterferon- -2b plus ribavirin [Peg-Intron plus Rebetol; Schering-Plough] have been recommended for approval

By  

Inpharma, Vol. 1, Iss. 1459, 2004-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Three new MiniQuick formulations of Pfizer's somatropin [Genotropin] have been launched in Japan

By  

Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Verteporfin recommended for approval in the EU

By  

Inpharma, Vol. 1, Iss. 1269, 2001-01 ,pp. : 25-25

Adis International

Access to resources Recommend Favorite

Expanded approval for buccal fentanyl not recommended.

By  

Inpharma, Vol. 1, Iss. 1638, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Approval recommendations in Japan

By  

Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite